WebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) Yahoo. 04/03 16:00. UBS Adjusts Cytokinetics Price Target to $61 From $67, Maintains Buy Rating. MT Newswires. 04/03 10:50. Cantor Fitzgerald Adjusts Price Target on Cytokinetics to $59 From $61, Maintains Overweight Rating. MT Newswires. WebJul 23, 2024 · SOUTH SAN FRANCISCO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the closing of its previously …
Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Can the …
WebApr 29, 2004 · Investor Relations Cytokinetics, Inc. 350 Oyster Point Blvd South San Francisco, CA 94080 Phone: 650-624-3060 Fax: 650-624-3070 Email: [email protected] Back to top Feb 14 2024 8:39 am EST Data Provided by Refinitiv. Minimum 15 minutes delayed. STOCK CHART SHAREHOLDER TOOLS Print … WebFeb 9, 2024 · As of February 8, 2024, the average one-year price target for Cytokinetics is $63.31. The forecasts range from a low of $47.47 to a high of $84.00. The average price target represents an increase... gran turismo hot wheels
Investor Relations Cytek Biosciences
WebMar 1, 2024 · Cytokinetics, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.96 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by... WebSep 23, 2024 · SOUTH SAN FRANCISCO, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK), today announced that it will host an Analyst … WebApr 10, 2024 · CYTK. KK3A. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated ( Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 … chipotle naples